CRP and enthesitis-related juvenile idiopathic arthritis: Subsequently, the treatment of ERA children in Group B was converted to anti-TNF, and at 18 months of follow-up, CRP (7.00 ± 1.84, P = 0.000) and ESR (8.54 ± 5.46, P = 0.010) were significantly lower than that at baseline.